Company Filing History:
14 out of 35 
2 out of 2 
1 out of 20 Years Active: 2011-2024
Title: Innovations by Shi-Jiang Lu in Stem Cell Research
Introduction
Shi-Jiang Lu, based in Shrewsbury, MA, has made significant contributions to the field of stem cell research, holding an impressive 18 patents. His work focuses primarily on the production of human hemogenic endothelial cells and platelets from pluripotent stem cells, offering promising advancements in regenerative medicine.
Latest Patents
Lu's latest patents are groundbreaking methodologies for producing human hemogenic endothelial cells and platelets from pluripotent stem cells such as human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs). Notably, these innovative methods enable production without the formation of embryoid bodies or clusters of pluripotent stem cells, eliminating the need for stromal inducer cells. Furthermore, they boast improved yield and purity compared to prior techniques. Lu’s patents also include compositions and pharmaceutical preparations containing platelets derived from these advancements, which are vital for therapeutic applications.
Career Highlights
Throughout his career, Shi-Jiang Lu has been associated with esteemed organizations, including the Astellas Institute for Regenerative Medicine and Stem Cell & Regenerative Medicine International, Inc. His research has significantly influenced practices in regenerative medicine and has opened new avenues for clinical applications in treating various medical conditions.
Collaborations
Lu has collaborated with notable figures in the field, including Robert P. Lanza and Qiang Feng. Together, they have been instrumental in advancing the understanding and application of stem cell technology, leveraging their collective expertise to push the boundaries of regenerative medicine.
Conclusion
Shi-Jiang Lu's innovative work in stem cell research exemplifies the potential of technology to transform medical practices. With 18 patents to his name, Lu continues to contribute to the scientific community, paving the way for future advancements in cell therapy and regenerative medicine. His dedication to innovation positions him as a key player in the ongoing evolution of this vital field.